Sponsor study identifier
observational
583
1 country
23
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2010
Actual (reported)Study Completion
March 2011
Actual (reported)The purpose of this study is to determine the clinically meaningful definition and prevalence of aspirin resistance based on data linking aspirin-dependent laboratory tests to recurrent vascular events in cardiovascular patients taking aspirin.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
November 7, 2005
Actual (reported)November 8, 2005
Actual (reported)June 2010
Actual (reported)March 2011
Actual (reported)out-patient clinic
Research Institute for Brain and Blood Vessels Akita
Akita, Akita, 0100874, Japan
National Fukuoka-Higashi Medical Center
Koga, Fukuoka, 8113195, Japan
Hokkaido Neurosurgical Memorial Hospital
Sapporo, Hokkaido, 0600022, Japan
Nakamura Memorial Hospital
Sapporo, Hokkaido, 0600061, Japan
Ohnishi Neurological Center
Akashi, Hyōgo, 674-0064, Japan
Higashi Takarazuka Satoh Hospital
Takarazuka, Hyōgo, 6650973, Japan
Kagawa University School of Medicine
Kida-gun, Kagawa-ken, 7610793, Japan
whole blood, serum, urine
Toshiyuki Miyata, PhD
National Cardiovascular Center, Research Institute,
Shigeki Miyata, MD
National Cerebral and Cardiovascular Center, Japan
Kazuo Minematsu, MD
National Cerebral and Cardiovascular Center, Japan
Masafumi Kitakaze, MD, PhD
National Cerebral and Cardiovascular Center, Japan
583 participants (actual enrollment reported by the registry).
First Submitted
November 7, 2005
First Posted
November 8, 2005
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
Contact the study team to confirm eligibility.
Tokai University School of Medicine
Isehara, Kanagawa, 2591193, Japan
Kumamoto University Graduate School of Medicine
Kumamoto, Kumamoto, 8608556, Japan
Mie University Graduate School of Medicine
Tsu, Mie-ken, 5148507, Japan
Kohnan Hospital
Sendai, Miyagi, 9828523, Japan
Nagoya City University Graduate School of Medical Sciences
Nagoya, Nagoya, 4678602, Japan
Nara Medical University
Kashihara, Nara, 6348521, Japan
Sado Hospital
Sado, Niigata, 9521209, Japan
Kawasaki Medical School
Kurashiki, Okayama-ken, 7010192, Japan
Osaka University Graduate School of Medicine
Suita, Osaka, 5650871, Japan
National Cardiovascular Center
Suita, Osaka, 5658565, Japan
National Hospital Organization Ureshino Medical Center
Fujitsu-gun, Saga-ken, 8430393, Japan
Jichi Medical School
Kawachi-gun, Tochigi, 3290498, Japan
Nippon Medical School Hospital
Tokyo, Tokyo, 1138603, Japan
Tokyo Metropolitan Ebara Hospital
Tokyo, Tokyo, 1450065, Japan
Tokyo Women's Medical University
Tokyo, Tokyo, 1628666, Japan
Teikyo University
Tokyo, Tokyo, 1738606, Japan
Kazuyuki Nagatsuka, MD, PhD
National Cerebral and Cardiovascular Center, Japan
Atsushi Kawamura, MD, PhD
National Cerebral and Cardiovascular Center, Japan
Akiko Kada, MPH
National Cerebral and Cardiovascular Center, Japan
Shinichiro Uchiyama, MD
Tokyo Women's Medical University
Takehiko Nagao, MD, PhD
Tokyo Metropolitan Ebara Hospital
Naohisa Hosomi, MD, PhD
Kagawa University School of Medicine
Takemori Yamawaki, MD, PhD
Nagoya City University Graduate School of Medical Science
Kazumi Kimura, MD, PhD
Kawasaki Medical School
Kozue Saito, MD
Nara Medical University
Hiroshi Nakane, MD
National Fukuoka-Higashi Medical Center
Jyoji Nakagawara, MD
Nakamura Memorial Hospital
Shinya Goto, MD
Tokai University School of Medicine
Takaaki Isshiki, MD
Teikyo University
Kazuo Kitagawa, MD
Osaka University Graduate School of Medicine
Kazuomi Kario, MD
Jichi Medical School
Hideo Wada, MD, PhD
Mie University Graduate School of Medicine
Ken Nagata, MD
Research Institute for Brain and Blood Vessels Akita
Koichi Kaikita, MD
Kumamoto University Graduate School of Medicine
Keiji Tanaka, MD
Nippon Medical School Hospital
Akira Hattori, MD
Sado Hospital
Eisuke Furui, MD, PhD
Kohnan Hospital
Yoshihiko Saito, MD, PhD
Nara Medical University
Satoshi Ueno, MD
Nara Medical University
Yasuo Katayama, MD
Nippon Medical School Hospital
Takeo Abumiya, MD
Hokkaido Neurosurgical Memorial Hospital
Masakatsu Nishikawa, MD
Mie University Graduate School of Medicine
Shin Takiuchi, MD, PhD
Higashi Takarazuka Satoh Hospital
Hideyuki Ohnishi, MD
Ohnishi Neurological Center
Primary Completion
June 2010
Actual (reported)Study Completion
March 2011
Actual (reported)Last Updated
December 13, 2011
Record last verified: 2011-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: